Viva’s drive is saving lives by reducing in-hospital mortality from sepsis, which is the leading cause of in-hospital deaths in the world. Our mission is to develop advanced and easy-to-use devices to solve the current problem of stratification of patients in sepsis, and in other inflammatory processes; as well as contributing to the development of novel therapies using cutting-edge scientific knowledge in the area of inflammasomes." title="" class="btn" data-container="body" data-html="true" data-id="188263" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Viva In Vitro"> 1,480
Activities
Technologies
Entity types
Location
Carr de Madrid, Murcia, Spain
Murcia
Spain
Employees
Scale: 2-10
Estimated: 8
Engaged corporates
4Added in Motherbase
1 year, 11 months agoDeveloping novel diagnostics compact devices to enable hospitals a better stratification of sepsis in patients.
Viva’s drive is saving lives by reducing in-hospital mortality from sepsis, which is the leading cause of in-hospital deaths in the world.
Our mission is to develop advanced and easy-to-use devices to solve the current problem of stratification of patients in sepsis, and in other inflammatory processes; as well as contributing to the development of novel therapies using cutting-edge scientific knowledge in the area of inflammasomes.
sepsis , IVD, diagnostics, medical devices, biotech, prognosis, stratification, septic shock, acute inflammation, inflammatory diseases, inflammasomes, nlrp3, biomedical, and código sepsis
Hemos completado con éxito la prueba de concepto clínica con el apoyo del European Research Council demostrando que podemos identificar los pacientes con sepsis y pronosticar su evolución con máxima especificidad y con mayor sensibilidad y mucho más rápido que los sistemas actuales.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Other 8 Feb 2025 | | |
![]() CaixaBank Bank, Banking | CaixaBank Bank, Banking | Other 30 Sep 2024 | | |
![]() Banco Sabadell Bank, Information Technology and Services | Banco Sabadell Bank, Information Technology and Services | Other 27 Oct 2024 | | |
![]() Ship2B Foundation Business Consulting and Services | Ship2B Foundation Business Consulting and Services | Other 27 Jul 2024 | |